Dong Sung Bio Pharm.Co.,Ltd.

KSE 002210.KS

Dong Sung Bio Pharm.Co.,Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 30.57 M

Dong Sung Bio Pharm.Co.,Ltd. Shareholders' Equity is USD 30.57 M for the year ending December 31, 2023, a -9.61% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Dong Sung Bio Pharm.Co.,Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 33.82 M, a -13.00% change year over year.
  • Dong Sung Bio Pharm.Co.,Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 38.87 M, a -22.94% change year over year.
  • Dong Sung Bio Pharm.Co.,Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 50.44 M, a -16.52% change year over year.
  • Dong Sung Bio Pharm.Co.,Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 60.42 M, a 17.58% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
KSE: 002210.KS

Dong Sung Bio Pharm.Co.,Ltd.

CEO Mr. Yang-Gu Lee
IPO Date Jan. 4, 2000
Location South Korea
Headquarters Dongsung Building
Employees 298
Sector Consumers Staples
Industries
Description

Dong Sung Bio Pharm.Co.,Ltd. engages in the pharmaceuticals, cosmetics, hair dye, and photodynamic therapy businesses in South Korea. It offers OTC drugs, such as liver disease treatment, climacterium, skin disease, obesity, digestive, gingival, alopecia, antipyretic, analgesic, anti-inflammatory, respiratory, scar-recovery, sleep inducer, antidiarrhotica, antiemetic, antiviral, blood circulation enhancer, antifungal, and anti-histamine drugs, as well as keratin softeners, optic nutrition supplements, and vitamins. The company also provides ETC drugs, including endocrine, gastrointestinal, circulatory, neuropsychologic, tumor, analgesic/anti-inflammation, dermato-urinary, anti-viral, antibiotic, antifungal, anti-histamine, and respiratory drugs, as well as steroids and eye drops. In addition, it offers hair dyeing agents, health functional foods, medical devices, daily supplies, muscle taping products, disinfectants, toothpastes, anti-hair loss and hair increase shampoos, sanitary pads, and other products. The company was founded in 1957 and is headquartered in Seoul, South Korea.

Similar companies

000640.KS

Dong-A Socio Holdings Co., Ltd.

USD 65.38

-0.04%

001630.KS

Chong Kun Dang Holdings Corp.

USD 31.05

-1.12%

003000.KS

Bukwang Pharmaceutical Co., Ltd.

USD 3.10

-3.13%

003060.KS

Aprogen pharmaceuticals,Inc.

USD 0.50

-4.09%

000020.KS

Dongwha Pharm.Co.,Ltd

USD 4.07

-1.95%

StockViz Staff

February 4, 2025

Any question? Send us an email